Radiomics in precision oncology: hype or ludum mutante.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

1 citing paper in PubMed.

1. Development and validation of a multi-modality system combining radiomics and deep learning for predicting mid-pregnancy complications and enabling timely pregnancy care.Frontiers in pediatrics · 2025
   Article

Corrections and comments

• Comment on
  Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.2023

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as